A post mortem study in 26 patients reported ACE-2 expression in the diaphragm of COVID-19 ICU and control ICU patients providing an entry point for COVID-19 to infect diaphragm myofibres, which suggested a possible infectious involvement of the diaphragm [7, 8]. Here, ACE2 is linked to COVID-19.